Mr Nordkamp, who is UK Managing Director for Pfizer Ltd, took up his role at King’s on 1 January.
Mr Nordkamp has been Managing Director for Pfizer Ltd since February 2015, having worked at the company in other senior roles since 2010. These roles include President and Managing Director, Greece, Cyprus and Malta (2012-15) and Regional Strategy Lead (2010-12).
Prior to this, Mr Nordkamp worked at Eli Lilly and Company as European Senior Director of Transformation and Lean Six Sigma. He has an MSc in Biomedical Sciences from Radboud University, Nijmegen (1992) and an MBA from the Erasmus University Rotterdam (1999).
He is originally from Holland but lives and works in the UK. He is married with two children.
Commenting on Mr Nordkamp’s appointment, Lord Bob Kerslake, Chair of King’s College Hospital NHS Foundation Trust, said:
“Erik brings a wealth of experience to the role. His track record in business and organisational transformation speaks for itself, and helps to strengthen the King’s Board at a critical time for the Trust. I’m delighted he has decided to join the Board, and look forward to working with him.”
Erik Nordkamp said: “I am honoured and delighted to join such a respected and internationally recognised health care organisation and look forward to contributing to its future success.”
Mr Nordkamp’s role as a Non-Executive Director at King’s will involve a monthly commitment of up to three days. He will continue in his current role as UK Managing Director for Pfizer Ltd.